Shimadzu Corporation has acquired a 75% stake of the outstanding shares of German startup Plasmion GmbH (headquartered in Augsburg, Bavaria) on March 23, making the company a subsidiary. This acquisition aims to obtain Plasmion’s mass spectrometer (MS) ion source technology SICRIT（Soft Ionization by Chemical Reaction In Transfer）.

岛津制作所于3月23日收购了德国初创企业Plasmion有限公司（总部位于巴伐利亚州奥格斯堡）75%的已发行股份，使其成为子公司。此次收购旨在获取Plasmion的质谱仪（MS）离子源技术SICRIT（传输中的化学反应软电离）。

※

※

and related technologies to strengthen Shimadzu’s MS business.

以及相关技术，以加强岛津的质谱业务。

SICRIT is a groundbreaking technology that overcomes the limitations of the widely used APCI (atmospheric pressure chemical ionization) method in liquid chromatography–mass spectrometry (LC–MS) and similar applications. Its chief feature is the ability to directly ionize analytes with high sensitivity without complex sample pretreatment, enabling high-sensitivity real-time analysis that was previously difficult.

SICRIT是一项突破性的技术，克服了在液相色谱-质谱联用（LC-MS）及类似应用中广泛使用的APCI（大气压化学电离）方法的局限性。其主要特点是能够以高灵敏度直接电离分析物，无需复杂的样品预处理，从而实现以往难以做到的高灵敏度实时分析。

It is already being used in applications such as the search for disease markers in exhaled breath in the healthcare field, monitoring trace hazardous substances in the environment, and non-destructive analysis of aroma components in food and beverages..

它已被用于医疗保健领域的呼气中寻找疾病标志物、环境中的痕量有害物质监测、食品和饮料的香气成分的无损分析等应用。

Shimadzu and Plasmion have been collaborating since 2019 through exchanges of technical information, lending of Shimadzu products, and development of SICRIT applications. Plasmion’s founders, CEO Dr. Thomas Wolf and CTO Dr. Jan-Christoph Wolf, will continue to hold 25% of the company’s shares and remain involved in management.

岛津与Plasmion自2019年以来通过技术信息交流、岛津产品出借以及SICRIT应用开发等方式展开合作。Plasmion的创始人，首席执行官托马斯·沃尔夫博士和首席技术官扬-克里斯托夫·沃尔夫博士将继续持有公司25%的股份，并参与公司的经营管理。

Shimadzu will develop next-generation mass spectrometers by integrating the SICRIT technology with its MS-related technologies..

岛津将通过将SICRIT技术与其质谱相关技术相结合，开发下一代质谱仪。

https://www.bionity.com/en/news/1188592/shimadzu-acquires-german-startup-plasmion-and-its-sicrit-ionization-technology.html

https://www.bionity.com/zh/news/1188592/岛津收购德国初创公司Plasmion及其SICRIT电离技术.html

Bruker Announces Acquisition of biocrates

布鲁克宣布收购生物克拉特斯

The acquisition further enhances Bruker’s MS-based metabolomics solutions

这次收购进一步增强了布鲁克基于质谱的代谢组学解决方案。

Read news

读新闻

Most read news

最受关注的新闻

1

1

Start-up AveThera acquires Fraunhofer site for biologics production

初创公司AveThera收购弗劳恩霍夫生物制品生产场地

2

2

1.7 trillion euros of high-tech potential lies untapped in Germany

1.7万亿欧元的高科技潜力在德国尚未开发

3

3

Parents' consumption of artificial sweeteners could affect their children's metabolism

父母摄入人工甜味剂可能会影响孩子的代谢。

4

4

Helium shortage jeopardizes pharmaceutical production

氦气短缺危及制药生产

5

5

A copper complex kills cancer cells 100 times more effectively than conventional chemotherapy drugs

一种铜复合物杀死癌细胞的效果比常规化疗药物高100倍。

Topics

主题

aquisition

获取

ion sources

离子源

mass spectrometry

质谱分析

real-time analysis

实时分析

Show all

显示全部

Show less

显示较少

Organizations

组织机构

Shimadzu

岛津

Plasmion

普拉米昂